GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (HAM:SYAB) » Definitions » Research & Development

Synlab AG (HAM:SYAB) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Synlab AG's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Synlab AG Research & Development Historical Data

The historical data trend for Synlab AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Research & Development Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
- - - -

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Synlab AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synlab AG  (HAM:SYAB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Synlab AG Research & Development Related Terms

Thank you for viewing the detailed overview of Synlab AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlab AG (HAM:SYAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (HAM:SYAB) » Definitions » Research & Development
Comparable Companies
XTER:NN6 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS XPAR:BIM RVTY XPAR:ERF ASX:SHL QGEN
Traded in Other Exchanges
SYAB:Germany
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Website
https://www.synlab.de
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (HAM:SYAB) Headlines

No Headlines